Psychemedics Corp. (NASDAQ:PMD) on 11/09/2022 declared a dividend of $ 0.0700 per share payable on December 16, 2022 to shareholders of record as of December 02, 2022.
Psychemedics Corp. (NASDAQ:PMD) has paid dividends since 2002, has a current dividend yield of 4.4374008179% and has increased its dividends for 0 successive years.
Psychemedics Corp.'s market cap is $ 35,500,060 and has a PE ratio of 0.00. The stock price closed yesterday at $ 6.31 and has a 52 week low/high of $ 6.01 and $ 8.90.
Psychemedics provides testing services for the detection of drugs of abuse through the analysis of hair samples. Co.'s testing methods utilize a technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. Co. provides screening and confirmation by mass spectrometry for cocaine, marijuana, PCP, amphetamines (including ecstasy, eve and Adderall®), opiates (including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone and codeine), synthetic cannabinoids (including K2, Spice, Blaze), benzodiazepines (Xanax®, Valium®, and Ativan®), nicotine and Fentanyl.
For more information on Psychemedics Corp. click here.
Psychemedics Corp. current dividend information as per the date of this press release is:
